Patents by Inventor Halvor Sommerfelt

Halvor Sommerfelt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine
    Patent number: 10166279
    Abstract: A mutant of an E coli heat-stable toxin (ST) having the following wild-type sequence: NSSNYCCELCCNPACTGCY wherein the mutant comprises a mutation selected from the group consisting of: A14H, A14T and N12T.
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: January 1, 2019
    Assignees: Bergen Teknologioverføring, The Administrators of the Tulane Educational Fund
    Inventors: Pål Puntervoll, Halvor Sommerfelt, John Clements, James P. Nataro, Weiping Zhang, Arne M. Taxt
  • Vaccine
    Publication number: 20160220654
    Abstract: A mutant of an E coli heat-stable toxin (ST) having the following wild-type sequence: NSSNYCCELCCNPACTGCY wherein the mutant comprises a mutation selected from the group consisting of: A14H, A14T and N12T.
    Type: Application
    Filed: February 20, 2014
    Publication date: August 4, 2016
    Inventors: Pål Puntervoll, Halvor Sommerfelt, John Clements, James P. Nataro, Weiping Zhang, Arne M. Taxt
  • Immune response potentiation
    Publication number: 20040131643
    Abstract: The invention provides the use of a physiologically tolerable zinc compound for the manufacture of a medicament for use in a method of treatment of an animal to generate a mucosal immune response therein to an antigen, which method comprises administering to said animal a said physiologically tolerable zinc compound and a said antigen whereby to generate said response, preferably by bringing said zinc compound and said antigen into contact with a mucosal surface in said animal.
    Type: Application
    Filed: February 27, 2004
    Publication date: July 8, 2004
    Inventors: Harleen Grewal, Halvor Sommerfelt